.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids.
    Pharmaceutical biology (Pharm Biol ) Vol: 49 Issue 4 Pages: 396-402
    Pub: 2011 Apr Epub: 2011 Mar 11
    • Ozçelik B
    • Kartal M
    • Orhan I

  2. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats.
    PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529
    Pub: 2012 Epub: 2012 Aug 3
    • Zhang X
    • Zhao Y
    • Zhang M
    • Pang X
    • Xu J
    • Kang C
    • Li M
    • Zhang C
    • Zhang Z
    • Zhang Y
    • Li X
    • Ning G
    • Zhao L

  3. Antibacterial in vitro effects of preparations from Anthroposophical Medicine.
    BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 16 Issue 1 Pages: 372
    Pub: 2016 Sep 22 Epub: 2016 Sep 22
    • Roser E
    • Gründemann C
    • Engels I
    • Huber R

  4. Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese.
    Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671
    Pub: 2016 Jun 10 Epub: 2016 Jun 10
    • Alolga RN
    • Fan Y
    • Chen Z
    • Liu LW
    • Zhao YJ
    • Li J
    • Chen Y
    • Lai MD
    • Li P
    • Qi LW

  5. Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci ) Vol: 100 Issue Pages: 211-218
    Pub: 2017 Mar 30 Epub: 2017 Jan 21
    • Ikarashi N
    • Ogawa S
    • Hirobe R
    • Kon R
    • Kusunoki Y
    • Yamashita M
    • Mizukami N
    • Kaneko M
    • Wakui N
    • Machida Y
    • Sugiyama K

  6. Toxicity of Methylated Bismuth Compounds Produced by Intestinal Microorganisms to Bacteroides thetaiotaomicron, a Member of the Physiological Intestinal Microbiota.
    Journal of toxicology (J Toxicol ) Vol: 2011 Issue Pages: 608349
    Pub: 2011 Epub: 2011 Sep 28
    • Bialek B
    • Diaz-Bone RA
    • Pieper D
    • Hollmann M
    • Hensel R

  7. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens.
    Gut microbes (Gut Microbes ) Vol: 6 Issue 2 Pages: 93-100
    Pub: 2015 Epub:
    • Pitz AM
    • Park GW
    • Lee D
    • Boissy YL
    • Vinjé J

  8. Nutritional Correlates of Human Oral Microbiome.
    Journal of the American College of Nutrition (J Am Coll Nutr ) Vol: 36 Issue 2 Pages: 88-98
    Pub: 2017 Feb Epub: 2016 Oct 31
    • Kato I
    • Vasquez A
    • Moyerbrailean G
    • Land S
    • Djuric Z
    • Sun J
    • Lin HS
    • Ram JL

  9. In vitro antibacterial activity of bismuth subsalicylate.
    Reviews of infectious diseases (Rev Infect Dis ) Vol: 12 Suppl 1 Issue Pages: S9-10
    Pub: 1990 Jan-Feb Epub:
    • Cornick NA
    • Silva M
    • Gorbach SL

  10. Misc articles
    ppt-health.com (ppt-health.com ) Vol: Issue Pages:
    Pub: Jan 2018 Epub:
    • ppt-health.com

Full list available by paid subscriptions

For More information see this summary.


This site is a free site and intended to stay a free site! If this site is really helpful and you are loaded with money -- Amazon Gift cards are always appreciated to defer operating costs.;-)